vs
Side-by-side financial comparison of ORTHOPEDIATRICS CORP (KIDS) and Nano Dimension Ltd. (NNDM). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $57.8M, roughly 1.1× Nano Dimension Ltd.). ORTHOPEDIATRICS CORP runs the higher net margin — -16.4% vs -171.1%, a 154.7% gap on every dollar of revenue. ORTHOPEDIATRICS CORP produced more free cash flow last quarter ($9.7M vs $-21.1M).
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
Nano Dimension Ltd. is a leading provider of additively manufactured electronics solutions and 3D printing technologies. It designs high-precision 3D printers, related materials, and software for producing printed circuit boards, microelectronics components, and multi-layer electronic devices, serving aerospace, defense, medical, automotive, and industrial electronics segments across global markets.
KIDS vs NNDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $61.6M | $57.8M |
| Net Profit | $-10.1M | $-98.8M |
| Gross Margin | 73.2% | 43.1% |
| Operating Margin | -13.3% | -155.1% |
| Net Margin | -16.4% | -171.1% |
| Revenue YoY | 17.0% | — |
| Net Profit YoY | 37.1% | — |
| EPS (diluted) | $-0.43 | $-0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.6M | — | ||
| Q3 25 | $61.3M | — | ||
| Q2 25 | $61.1M | — | ||
| Q1 25 | $52.4M | — | ||
| Q4 24 | $52.7M | $57.8M | ||
| Q3 24 | $54.6M | — | ||
| Q2 24 | $52.8M | $28.4M | ||
| Q1 24 | $44.7M | — |
| Q4 25 | $-10.1M | — | ||
| Q3 25 | $-11.8M | — | ||
| Q2 25 | $-7.1M | — | ||
| Q1 25 | $-10.7M | — | ||
| Q4 24 | $-16.1M | $-98.8M | ||
| Q3 24 | $-7.9M | — | ||
| Q2 24 | $-6.0M | $-79.2M | ||
| Q1 24 | $-7.8M | — |
| Q4 25 | 73.2% | — | ||
| Q3 25 | 73.9% | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 73.0% | — | ||
| Q4 24 | 67.5% | 43.1% | ||
| Q3 24 | 73.4% | — | ||
| Q2 24 | 77.3% | 45.8% | ||
| Q1 24 | 72.0% | — |
| Q4 25 | -13.3% | — | ||
| Q3 25 | -15.4% | — | ||
| Q2 25 | -17.4% | — | ||
| Q1 25 | -21.0% | — | ||
| Q4 24 | -26.7% | -155.1% | ||
| Q3 24 | -10.2% | — | ||
| Q2 24 | -10.7% | — | ||
| Q1 24 | -21.8% | — |
| Q4 25 | -16.4% | — | ||
| Q3 25 | -19.2% | — | ||
| Q2 25 | -11.6% | — | ||
| Q1 25 | -20.3% | — | ||
| Q4 24 | -30.5% | -171.1% | ||
| Q3 24 | -14.5% | — | ||
| Q2 24 | -11.4% | -279.4% | ||
| Q1 24 | -17.5% | — |
| Q4 25 | $-0.43 | — | ||
| Q3 25 | $-0.50 | — | ||
| Q2 25 | $-0.30 | — | ||
| Q1 25 | $-0.46 | — | ||
| Q4 24 | $-0.70 | $-0.45 | ||
| Q3 24 | $-0.34 | — | ||
| Q2 24 | $-0.26 | $-0.35 | ||
| Q1 24 | $-0.34 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.9M | $317.2M |
| Total DebtLower is stronger | $106.0M | — |
| Stockholders' EquityBook value | $346.6M | $860.0M |
| Total Assets | $508.6M | $902.5M |
| Debt / EquityLower = less leverage | 0.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.9M | — | ||
| Q3 25 | $57.7M | — | ||
| Q2 25 | $70.1M | — | ||
| Q1 25 | $58.8M | — | ||
| Q4 24 | $68.8M | $317.2M | ||
| Q3 24 | $76.1M | — | ||
| Q2 24 | $28.9M | $231.8M | ||
| Q1 24 | $47.7M | — |
| Q4 25 | $106.0M | — | ||
| Q3 25 | $105.3M | — | ||
| Q2 25 | $102.7M | — | ||
| Q1 25 | $77.4M | — | ||
| Q4 24 | $77.5M | — | ||
| Q3 24 | $76.9M | — | ||
| Q2 24 | $11.2M | — | ||
| Q1 24 | $11.3M | — |
| Q4 25 | $346.6M | — | ||
| Q3 25 | $349.3M | — | ||
| Q2 25 | $355.5M | — | ||
| Q1 25 | $347.1M | — | ||
| Q4 24 | $354.6M | $860.0M | ||
| Q3 24 | $370.9M | — | ||
| Q2 24 | $371.3M | $870.3M | ||
| Q1 24 | $370.6M | — |
| Q4 25 | $508.6M | — | ||
| Q3 25 | $493.5M | — | ||
| Q2 25 | $503.6M | — | ||
| Q1 25 | $470.3M | — | ||
| Q4 24 | $473.2M | $902.5M | ||
| Q3 24 | $489.3M | — | ||
| Q2 24 | $430.8M | $911.0M | ||
| Q1 24 | $437.2M | — |
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.22× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.03× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.3M | $-18.9M |
| Free Cash FlowOCF − Capex | $9.7M | $-21.1M |
| FCF MarginFCF / Revenue | 15.8% | -36.5% |
| Capex IntensityCapex / Revenue | 1.0% | 3.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.3M | — | ||
| Q3 25 | $-581.0K | — | ||
| Q2 25 | $-10.5M | — | ||
| Q1 25 | $-4.2M | — | ||
| Q4 24 | $-4.0M | $-18.9M | ||
| Q3 24 | $-10.3M | — | ||
| Q2 24 | $-6.1M | $-30.7M | ||
| Q1 24 | $-6.7M | — |
| Q4 25 | $9.7M | — | ||
| Q3 25 | $-3.4M | — | ||
| Q2 25 | $-13.9M | — | ||
| Q1 25 | $-8.4M | — | ||
| Q4 24 | $-4.2M | $-21.1M | ||
| Q3 24 | $-11.7M | — | ||
| Q2 24 | $-12.8M | — | ||
| Q1 24 | $-13.2M | — |
| Q4 25 | 15.8% | — | ||
| Q3 25 | -5.6% | — | ||
| Q2 25 | -22.8% | — | ||
| Q1 25 | -16.0% | — | ||
| Q4 24 | -8.1% | -36.5% | ||
| Q3 24 | -21.4% | — | ||
| Q2 24 | -24.2% | — | ||
| Q1 24 | -29.4% | — |
| Q4 25 | 1.0% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 8.1% | — | ||
| Q4 24 | 0.5% | 3.8% | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 12.7% | — | ||
| Q1 24 | 14.5% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
